Cargando…
Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
Background: Patients with chronic kidney disease (CKD) undergoing dialysis often require intravenous iron for iron deficiency anemia (IDA). Materials and methods: The Ferumoxytol for Anemia of CKD Trial (FACT), a randomized, multicenter, open-label, phase 4 study, compared the long-term safety and e...
Autores principales: | Macdougall, Iain C., Strauss, William E., Dahl, Naomi V., Bernard, Kristine, Li, Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434426/ https://www.ncbi.nlm.nih.gov/pubmed/30802204 http://dx.doi.org/10.5414/CN109512 |
Ejemplares similares
-
The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017) -
Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018) -
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017) -
Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018) -
Ferumoxytol for the treatment of iron deficiency and iron-deficiency
anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021)